Sept. 9, 2008 -
PRLog -- Absenteeism and poor job performance resulting from hangovers cost the nation $148 billion annually, according to the Annals of Internal Medicine. Statistics show that 34% of Americans who consume alcohol are binge drinkers and over half (52%) of college students are binge drinkers.
DINOCO™ International Corporation (www.dinoco.us)
has recently been granted FDA OTC approval to begin marketing and selling its patent pending multi-symptom/
multi-dose reliever Formula No.49™ (caffeinated)
and Formula No.67™ (decaffeinated)
hangover relief medicines to retailers and consumers throughout the U.S. and announced today that it will be doing its part to help American business’ and the US economy by helping to reduce the $148 billion in annual losses to due to absenteeism and job performance by licensing its OTC hangover relief medicines to pharmaceutical suppliers, distributors, re-packagers, first aid service companies, vending suppliers and mass retailers on a private label basis in the US.
“We believe that by making our hangover relief medication available to the consumer products industry as a whole, we can help make a substantial difference in losses that occur due to overindulgence,”
stated Susanne Smally, DINOCO’S president. “It would be prudent for employers to make hangover relief medications available to employees at the company's first aid stations, job site care centers and vending machines. We live in a time where there is a medicine that can help alleviate most symptoms that consumers experience, and now there is a safe, effective and reliable solution for the common hangover that can help employees with attendance and performance challenges. This alone can save US companies billions of dollars annually,” stated Smalley.
In addition to packaging DINOCO'S hangover relief medicine in its Patent Pending, tamper-evident BookBox™
carton, DINOCO™ is producing single-dose (2-count) tamper-evident packets that fit in countertop displays, first aid kits, wall mount on floor mount vending machines and will custom package and label its packets and dispenser boxes to its customers specifications. DINOCO™ also offers a compact wall or floor mount medical vending dispenser for companies that want to charge employees for its medicine.
DINOCO’S™ Multi-Symptom Hangover Relief™ medicine consist of caffeine, acetaminophen and calcium carbonate caplets, which relieve symptoms of headache, fatigue, muscular aches, heartburn, sour stomach, upset stomach, pre-menstrual cramps, menstrual cramps and generalized aches and pains associated with a hangover. DINOCO’S Multi-Symptom Hangover Relief DECAF™ (non-caffeinated)
medicine consists of acetaminophen and calcium carbonate caplets, which relieve symptoms of headache, muscular aches, heartburn, sour stomach, upset stomach, menstrual cramps and generalized aches and pains associated with a hangover.
For additional information on DINOCO™ , visit our website at www.dinoco.us
For additional information on JACK'S™ Hangover Relief visit www.getyourjack.com
# # #
DINOCO™ International Corporation is the innovator of JACK'S Hangover Relief and JACK'S Hangover Relief DECAF (non-caffeinated)
medicines. DINOCO™ distributes its JACK'S brand name, and customize private label brands for select customers. DINOCO™ is a Diamond Sponsor of the #49 Team in the NASCAR Sprint Cup Series.
